Browsing Tag
Enfamil
2 posts
Reckitt Benckiser (LSE: RKT) holds FY2026 guidance at +4-5% despite Q1 cold season drag and Europe weakness
Reckitt Benckiser holds 2026 guidance at +4-5% LFL after Q1 shows 3.1% ex-seasonal growth. Emerging Markets surge but Europe drags. Read our analysis.
Why Abbott Laboratories (NYSE: ABT) faces more than a legal bill after $70m Chicago baby formula ruling
Abbott was ordered to pay $70 million in a Chicago baby formula case. Read what the NEC verdict could mean for litigation risk, strategy, and ABT stock.